IP Library Granted Patent US 7,963,936
Granted Patent B2
US 7,963,936 · App. 12/049,482 · Granted Jun 21, 2011

Systems and methods for managing information relating to medical fluids and containers therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,963,936
App. No.
12/049,482
Granted
Jun 21, 2011
Kind
B2
Abstract

The present invention relates to management of information relating to medical fluids, containers therefor, and medical fluid administration devices for administering such medical fluids to patients. Data tags (e.g., RFID tags) are generally associated with containers of the invention and may be electromagnetically read from and/or written to using an electromagnetic device, for example, that may be associated with a medical fluid administration device of the invention.

Claims (20)

1. A method of operation for a medical imaging system that includes an imaging apparatus and a contrast media injector, the contrast media injector being designed to have a syringe mounted thereto, and the contrast media injector having a powered drive ram that is designed to interface with a plunger of the syringe to move the plunger of the syringe forward and backward relative to a barrel of the syringe when the syringe is mounted on the contrast media injector, the method comprising:

electromagnetically reading data from a data tag of the syringe, wherein the syringe has medical fluid for use in a medical imaging procedure disposed therein, wherein the electromagnetically reading is conducted using an electromagnetic device of the contrast media injector;

transferring the data that is electromagnetically read to the imaging apparatus, wherein the data that is electromagnetically read and transferred comprises data regarding a used or unused status of the syringe; and

electronically checking the data that is electromagnetically read against a database of previously used syringes.

2. The method of claim 1 , wherein the checking is performed in order to block potential reuse of the syringe.

3. The method of claim 1 , wherein the data tag is associated with the barrel of the syringe.

4. The method of claim 1 , wherein the syringe is mounted to the contrast media injector during the electromagnetically reading.

5. The method of claim 1 , wherein the contrast media injector comprises a faceplate for mounting the syringe thereto.

6. The method of claim 1 , wherein the contrast media injector comprises a faceplate for mounting the syringe thereto.

7. A method of operation for a medical imaging system that includes an imaging apparatus and a contrast media injector, the contrast media injector being designed to have a syringe mounted thereto, and the contrast media injector having a powered drive ram that is designed to interface with a plunger of the syringe to move the plunger of the syringe forward and backward relative to a barrel of the syringe when the syringe is mounted on the contrast media injector, the method comprising:

electromagnetically reading data from a data tag of the syringe, wherein the syringe has medical fluid for use in a medical imaging procedure disposed therein, wherein the electromagnetically reading is conducted using an electromagnetic device of the contrast media injector; and

transferring the data that is electromagnetically read to the imaging apparatus, wherein the data that is electromagnetically read and transferred comprises data regarding a used or unused status of the syringe.

8. The method of claim 7 , wherein the data tag is associated with the barrel of the syringe.

9. The method of claim 7 , wherein the syringe is mounted to the contrast media injector during the electromagnetically reading.

10. A method of operation for a medical imaging system that includes an imaging apparatus and a contrast media injector, the contrast media injector being designed to have a syringe mounted thereto, and the contrast media injector having a powered drive ram that is designed to interface with a plunger of the syringe to move the plunger of the syringe forward and backward relative to a barrel of the syringe when the syringe is mounted on the contrast media injector, the method comprising:

electromagnetically reading data from a data tag of the syringe, wherein the syringe has medical fluid for use in a medical imaging procedure disposed therein, wherein the electromagnetically reading is conducted using an electromagnetic device of the contrast media injector;

expelling the medical fluid from the syringe using the contrast media injector;

transferring the data that is electromagnetically read to the imaging apparatus, wherein the data that is electromagnetically read and transferred comprises data regarding a used or unused status of the syringe; and

updating an imaging information system with data that includes a used status of the syringe.

11. The method of claim 10 , wherein the updating occurs after the expelling has been completed.

Assignments (4)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →